Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 63975 entries
Sorted by: Best Match Show Resources per page
Metabolomics analysis of the saliva in patients with chronic hepatitis B using nuclear magnetic resonance: a pilot study.

Iranian journal of basic medical sciences

Gilany K, Mohamadkhani A, Chashmniam S, Shahnazari P, Amini M, Arjmand B, Malekzadeh R, Nobakht Motlagh Ghoochani BF.
PMID: 31807248
Iran J Basic Med Sci. 2019 Sep;22(9):1044-1049. doi: 10.22038/ijbms.2019.36669.8733.

OBJECTIVES: Hepatitis B virus infection causes chronic disease such as cirrhosis and hepatocellular carcinoma. The metabolomics investigations have been demonstrated to be related to pathophysiologic mechanisms in many disorders such as hepatitis B infection. The aim of this study...

Cite
Gilany K, Mohamadkhani A, Chashmniam S, et al. Metabolomics analysis of the saliva in patients with chronic hepatitis B using nuclear magnetic resonance: a pilot study. Iran J Basic Med Sci. 2019;22(9):1044-1049doi: 10.22038/ijbms.2019.36669.8733.
Gilany, K., Mohamadkhani, A., Chashmniam, S., Shahnazari, P., Amini, M., Arjmand, B., Malekzadeh, R., & Nobakht Motlagh Ghoochani, B. F. (2019). Metabolomics analysis of the saliva in patients with chronic hepatitis B using nuclear magnetic resonance: a pilot study. Iranian journal of basic medical sciences, 22(9), 1044-1049. https://doi.org/10.22038/ijbms.2019.36669.8733
Gilany, Kambiz, et al. "Metabolomics analysis of the saliva in patients with chronic hepatitis B using nuclear magnetic resonance: a pilot study." Iranian journal of basic medical sciences vol. 22,9 (2019): 1044-1049. doi: https://doi.org/10.22038/ijbms.2019.36669.8733
Gilany K, Mohamadkhani A, Chashmniam S, Shahnazari P, Amini M, Arjmand B, Malekzadeh R, Nobakht Motlagh Ghoochani BF. Metabolomics analysis of the saliva in patients with chronic hepatitis B using nuclear magnetic resonance: a pilot study. Iran J Basic Med Sci. 2019 Sep;22(9):1044-1049. doi: 10.22038/ijbms.2019.36669.8733. PMID: 31807248; PMCID: PMC6880533.
Copy Download .nbib Format: NLM
Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma.

Frontiers in endocrinology

Feng JW, Pan H, Wang L, Ye J, Jiang Y, Qu Z.
PMID: 31275239
Front Endocrinol (Lausanne). 2019 Jun 19;10:363. doi: 10.3389/fendo.2019.00363. eCollection 2019.

No abstract available.

Cite
Feng JW, Pan H, Wang L, et al. Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma. Front Endocrinol (Lausanne). 2019;10:363doi: 10.3389/fendo.2019.00363.
Feng, J. W., Pan, H., Wang, L., Ye, J., Jiang, Y., & Qu, Z. (2019). Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma. Frontiers in endocrinology, 10363. https://doi.org/10.3389/fendo.2019.00363
Feng, Jia-Wei, et al. "Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma." Frontiers in endocrinology vol. 10 (2019): 363. doi: https://doi.org/10.3389/fendo.2019.00363
Feng JW, Pan H, Wang L, Ye J, Jiang Y, Qu Z. Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma. Front Endocrinol (Lausanne). 2019 Jun 19;10:363. doi: 10.3389/fendo.2019.00363. eCollection 2019. PMID: 31275239; PMCID: PMC6593058.
Copy Download .nbib Format: NLM
Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial.

BMJ paediatrics open

Zeevenhooven J, de Bruijn CMA, Vlieger A, Nieuwdorp M, Benninga MA.
PMID: 32864480
BMJ Paediatr Open. 2020 Aug 20;4(1):e000689. doi: 10.1136/bmjpo-2020-000689. eCollection 2020.

BACKGROUND: Irritable bowel syndrome (IBS) is a common chronic medical condition, in both children and adults. Despite the availability of effective (non)pharmacological treatments, symptoms persist in a significant amount of patients with IBS. Faecal microbiota transplantation (FMT) may be...

Cite
Zeevenhooven J, de Bruijn CMA, Vlieger A, et al. Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial. BMJ Paediatr Open. 2020;4(1):e000689doi: 10.1136/bmjpo-2020-000689.
Zeevenhooven, J., de Bruijn, C. M. A., Vlieger, A., Nieuwdorp, M., & Benninga, M. A. (2020). Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial. BMJ paediatrics open, 4(1), e000689. https://doi.org/10.1136/bmjpo-2020-000689
Zeevenhooven, Judith, et al. "Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial." BMJ paediatrics open vol. 4,1 (2020): e000689. doi: https://doi.org/10.1136/bmjpo-2020-000689
Zeevenhooven J, de Bruijn CMA, Vlieger A, Nieuwdorp M, Benninga MA. Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial. BMJ Paediatr Open. 2020 Aug 20;4(1):e000689. doi: 10.1136/bmjpo-2020-000689. eCollection 2020. PMID: 32864480; PMCID: PMC7443263.
Copy Download .nbib Format: NLM
The Berlin Declaration: Benchmark for India.

The Journal of the Association of Physicians of India

Kumar A, Kalra S.
PMID: 31331143
J Assoc Physicians India. 2018 Jun;66(6):84-85.

The diabetes epidemic knows no boundaries or borders, and is equally challenging for India as it is for the rest of the world. The Berlin Declaration of 2016 is a landmark event in modern diabetes care.1 Prepared by 23...

Cite
Kumar A, Kalra S. The Berlin Declaration: Benchmark for India. J Assoc Physicians India. 2018;66(6):84-85
Kumar, A., & Kalra, S. (2018). The Berlin Declaration: Benchmark for India. The Journal of the Association of Physicians of India, 66(6), 84-85.
Kumar, Arun, and Kalra, Sanjay. "The Berlin Declaration: Benchmark for India." The Journal of the Association of Physicians of India vol. 66,6 (2018): 84-85.
Kumar A, Kalra S. The Berlin Declaration: Benchmark for India. J Assoc Physicians India. 2018 Jun;66(6):84-85. PMID: 31331143.
Copy Download .nbib Format: NLM
Potential Use of Gluconate in Cancer Therapy.

Frontiers in oncology

Mycielska ME, Mohr MTJ, Schmidt K, Drexler K, Rümmele P, Haferkamp S, Schlitt HJ, Gaumann A, Adamski J, Geissler EK, Anand A, Fosso S, Gnanzou D.
PMID: 31275855
Front Oncol. 2019 Jun 19;9:522. doi: 10.3389/fonc.2019.00522. eCollection 2019.

We have recently discovered that cancer cells take up extracellular citrate through plasma membrane citrate transporter (pmCiC) and advantageously use citrate for their metabolism. Citrate uptake can be blocked with gluconate and this results in decreased tumor growth and...

Cite
Mycielska ME, Mohr MTJ, Schmidt K, et al. Potential Use of Gluconate in Cancer Therapy. Front Oncol. 2019;9:522doi: 10.3389/fonc.2019.00522.
Mycielska, M. E., Mohr, M. T. J., Schmidt, K., Drexler, K., Rümmele, P., Haferkamp, S., Schlitt, H. J., Gaumann, A., Adamski, J., Geissler, E. K., Anand, A., Fosso, S., & Gnanzou, D. (2019). Potential Use of Gluconate in Cancer Therapy. Frontiers in oncology, 9522. https://doi.org/10.3389/fonc.2019.00522
Mycielska, Maria E, et al. "Potential Use of Gluconate in Cancer Therapy." Frontiers in oncology vol. 9 (2019): 522. doi: https://doi.org/10.3389/fonc.2019.00522
Mycielska ME, Mohr MTJ, Schmidt K, Drexler K, Rümmele P, Haferkamp S, Schlitt HJ, Gaumann A, Adamski J, Geissler EK, Anand A, Fosso S, Gnanzou D. Potential Use of Gluconate in Cancer Therapy. Front Oncol. 2019 Jun 19;9:522. doi: 10.3389/fonc.2019.00522. eCollection 2019. PMID: 31275855; PMCID: PMC6593216.
Copy Download .nbib Format: NLM
Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease.

Cellular and molecular neurobiology

Zhang Z, Zhou Y, Zhao H, Xu J, Yang X.
PMID: 32880791
Cell Mol Neurobiol. 2020 Sep 03; doi: 10.1007/s10571-020-00953-9. Epub 2020 Sep 03.

Diabetic retinopathy, the most common complication of diabetes, is a neurodegenerative disease in the eye. And Parkinson's disease, affecting the health of 1-2% of people over 60 years old throughout the world, is the second largest neurodegenerative disease in...

Cite
Zhang Z, Zhou Y, Zhao H, et al. Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease. Cell Mol Neurobiol. 2020;doi: 10.1007/s10571-020-00953-9.
Zhang, Z., Zhou, Y., Zhao, H., Xu, J., & Yang, X. (2020). Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease. Cellular and molecular neurobiology, . https://doi.org/10.1007/s10571-020-00953-9
Zhang, Zhuoqing, et al. "Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease." Cellular and molecular neurobiology vol. (2020). doi: https://doi.org/10.1007/s10571-020-00953-9
Zhang Z, Zhou Y, Zhao H, Xu J, Yang X. Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease. Cell Mol Neurobiol. 2020 Sep 03; doi: 10.1007/s10571-020-00953-9. Epub 2020 Sep 03. PMID: 32880791.
Copy Download .nbib Format: NLM
ERRATUM FOR "Dynorphin and GABAA Receptor Signaling Contribute to Progesterone's Inhibition of the LH Surge in Female Mice".

Endocrinology

[No authors listed]
PMID: 32384136
Endocrinology. 2020 Jul 01;161(7). doi: 10.1210/endocr/bqaa071.

No abstract available.

Cite
ERRATUM FOR "Dynorphin and GABAA Receptor Signaling Contribute to Progesterone's Inhibition of the LH Surge in Female Mice". Endocrinology. 2020;161(7)doi: 10.1210/endocr/bqaa071.
(2020). ERRATUM FOR "Dynorphin and GABAA Receptor Signaling Contribute to Progesterone's Inhibition of the LH Surge in Female Mice". Endocrinology, 161(7), . https://doi.org/10.1210/endocr/bqaa071
"ERRATUM FOR "Dynorphin and GABAA Receptor Signaling Contribute to Progesterone's Inhibition of the LH Surge in Female Mice"." Endocrinology vol. 161,7 (2020). doi: https://doi.org/10.1210/endocr/bqaa071
ERRATUM FOR "Dynorphin and GABAA Receptor Signaling Contribute to Progesterone's Inhibition of the LH Surge in Female Mice". Endocrinology. 2020 Jul 01;161(7). doi: 10.1210/endocr/bqaa071. PMID: 32384136; PMCID: PMC7323866.
Copy Download .nbib Format: NLM
An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini- Review.

Endocrine, metabolic & immune disorders drug targets

Chatterjee A, Rajarshi K, Khan R, Ghosh H, Kapoor S, Ray S.
PMID: 32957898
Endocr Metab Immune Disord Drug Targets. 2021;21(9):1537-1543. doi: 10.2174/1871530320999200918143856.

There is close interdependence between cell survival, cell senescence, events of the cell cycle, apoptosis, malignancy development, and tumor responses to cancer treatment. Intensive studies and elaborate researches have been conducted on the functional aspects of oncogenes, tumor suppressor...

Cite
Chatterjee A, Rajarshi K, Khan R, et al. An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini- Review. Endocr Metab Immune Disord Drug Targets. 2021;21(9):1537-1543doi: 10.2174/1871530320999200918143856.
Chatterjee, A., Rajarshi, K., Khan, R., Ghosh, H., Kapoor, S., & Ray, S. (2021). An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini- Review. Endocrine, metabolic & immune disorders drug targets, 21(9), 1537-1543. https://doi.org/10.2174/1871530320999200918143856
Chatterjee, Aroni, et al. "An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini- Review." Endocrine, metabolic & immune disorders drug targets vol. 21,9 (2021): 1537-1543. doi: https://doi.org/10.2174/1871530320999200918143856
Chatterjee A, Rajarshi K, Khan R, Ghosh H, Kapoor S, Ray S. An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini- Review. Endocr Metab Immune Disord Drug Targets. 2021;21(9):1537-1543. doi: 10.2174/1871530320999200918143856. PMID: 32957898.
Copy Download .nbib Format: NLM
COVID-19, Diabetes and Ramadan.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Chowdhury TA, Waqar S, Hussain S, Ahmed SH, Syed A, Karamat A, Helmy A, Ghouri N.
PMID: 32880875
Diabetes Ther. 2020 Nov;11(11):2447-2451. doi: 10.1007/s13300-020-00887-x. Epub 2020 Sep 03.

No abstract available.

Cite
Chowdhury TA, Waqar S, Hussain S, et al. COVID-19, Diabetes and Ramadan. Diabetes Ther. 2020;11(11):2447-2451doi: 10.1007/s13300-020-00887-x.
Chowdhury, T. A., Waqar, S., Hussain, S., Ahmed, S. H., Syed, A., Karamat, A., Helmy, A., & Ghouri, N. (2020). COVID-19, Diabetes and Ramadan. Diabetes therapy : research, treatment and education of diabetes and related disorders, 11(11), 2447-2451. https://doi.org/10.1007/s13300-020-00887-x
Chowdhury, Tahseen A, et al. "COVID-19, Diabetes and Ramadan." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 11,11 (2020): 2447-2451. doi: https://doi.org/10.1007/s13300-020-00887-x
Chowdhury TA, Waqar S, Hussain S, Ahmed SH, Syed A, Karamat A, Helmy A, Ghouri N. COVID-19, Diabetes and Ramadan. Diabetes Ther. 2020 Nov;11(11):2447-2451. doi: 10.1007/s13300-020-00887-x. Epub 2020 Sep 03. PMID: 32880875; PMCID: PMC7471486.
Copy Download .nbib Format: NLM
Sex-dependent prolongation of sciatic nerve blockade in diabetes patients: a prospective cohort study.

Regional anesthesia and pain medicine

Tang S, Wang J, Tian Y, Li X, Cui Q, Xu M, Song X, Zheng Y, Yang H, Ma C, Zhan L, Zhu C, Zhang Y, Yao M, Huang Y.
PMID: 31302640
Reg Anesth Pain Med. 2019 Jul 12; doi: 10.1136/rapm-2019-100609. Epub 2019 Jul 12.

INTRODUCTION: Diabetes may affect the duration of nerve block after regional anesthesia. This study aimed to compare the durations of sensory and motor block in diabetes versus non-diabetes patients after lower limb nerve block and delineate any sex-based differences...

Cite
Tang S, Wang J, Tian Y, et al. Sex-dependent prolongation of sciatic nerve blockade in diabetes patients: a prospective cohort study. Reg Anesth Pain Med. 2019;doi: 10.1136/rapm-2019-100609.
Tang, S., Wang, J., Tian, Y., Li, X., Cui, Q., Xu, M., Song, X., Zheng, Y., Yang, H., Ma, C., Zhan, L., Zhu, C., Zhang, Y., Yao, M., & Huang, Y. (2019). Sex-dependent prolongation of sciatic nerve blockade in diabetes patients: a prospective cohort study. Regional anesthesia and pain medicine, . https://doi.org/10.1136/rapm-2019-100609
Tang, Shuai, et al. "Sex-dependent prolongation of sciatic nerve blockade in diabetes patients: a prospective cohort study." Regional anesthesia and pain medicine vol. (2019). doi: https://doi.org/10.1136/rapm-2019-100609
Tang S, Wang J, Tian Y, Li X, Cui Q, Xu M, Song X, Zheng Y, Yang H, Ma C, Zhan L, Zhu C, Zhang Y, Yao M, Huang Y. Sex-dependent prolongation of sciatic nerve blockade in diabetes patients: a prospective cohort study. Reg Anesth Pain Med. 2019 Jul 12; doi: 10.1136/rapm-2019-100609. Epub 2019 Jul 12. PMID: 31302640.
Copy Download .nbib Format: NLM
Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study.

Journal of clinical medicine

Ciudin A, Fidilio E, Ortiz A, Pich S, Salas E, Mesa J, Hernández C, Simó-Servat O, Lecube A, Simó R.
PMID: 31277226
J Clin Med. 2019 Jul 03;8(7). doi: 10.3390/jcm8070964.

INTRODUCTION: The aim of this pilot study was to assess genetic predisposition risk scores (GPS) in type 2 diabetic and non-diabetic patients in order to predict the better response to bariatric surgery (BS) in terms of either weight loss...

Cite
Ciudin A, Fidilio E, Ortiz A, et al. Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study. J Clin Med. 2019;8(7)doi: 10.3390/jcm8070964.
Ciudin, A., Fidilio, E., Ortiz, A., Pich, S., Salas, E., Mesa, J., Hernández, C., Simó-Servat, O., Lecube, A., & Simó, R. (2019). Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study. Journal of clinical medicine, 8(7), . https://doi.org/10.3390/jcm8070964
Ciudin, Andreea, et al. "Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study." Journal of clinical medicine vol. 8,7 (2019). doi: https://doi.org/10.3390/jcm8070964
Ciudin A, Fidilio E, Ortiz A, Pich S, Salas E, Mesa J, Hernández C, Simó-Servat O, Lecube A, Simó R. Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study. J Clin Med. 2019 Jul 03;8(7). doi: 10.3390/jcm8070964. PMID: 31277226; PMCID: PMC6679039.
Copy Download .nbib Format: NLM
Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy.

Annals of pediatric endocrinology & metabolism

Kim MS, Koh HJ, Lee GY, Kang DH, Kim SY.
PMID: 31261476
Ann Pediatr Endocrinol Metab. 2019 Jun;24(2):116-123. doi: 10.6065/apem.2019.24.2.116. Epub 2019 Jun 30.

PURPOSE: This study aimed to investigate the outcomes of gonadotropin-releasing hormone agonist (GnRHa) therapy with or without growth hormone (GH) therapy for girls with idiopathic central precocious puberty (CPP).METHODS: The medical records of 166 girls diagnosed with CPP from...

Cite
Kim MS, Koh HJ, Lee GY, et al. Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy. Ann Pediatr Endocrinol Metab. 2019;24(2):116-123doi: 10.6065/apem.2019.24.2.116.
Kim, M. S., Koh, H. J., Lee, G. Y., Kang, D. H., & Kim, S. Y. (2019). Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy. Annals of pediatric endocrinology & metabolism, 24(2), 116-123. https://doi.org/10.6065/apem.2019.24.2.116
Kim, Min Sub, et al. "Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy." Annals of pediatric endocrinology & metabolism vol. 24,2 (2019): 116-123. doi: https://doi.org/10.6065/apem.2019.24.2.116
Kim MS, Koh HJ, Lee GY, Kang DH, Kim SY. Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy. Ann Pediatr Endocrinol Metab. 2019 Jun;24(2):116-123. doi: 10.6065/apem.2019.24.2.116. Epub 2019 Jun 30. PMID: 31261476; PMCID: PMC6603606.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 63975 entries